Ausgabe 2/2001
Inhalt (12 Artikel)
Different clinicopathological features of hepatocellular carcinoma in relation to causative agents
Yasushi Shiratori, Haruhiko Yoshida, Masao Omata
Growth inhibition and apoptosis of gastric cancer cell lines by Anemarrhena asphodeloides Bunge
Yoshio Takeda, Hitoshi Togashi, Taku Matsuo, Haruhide Shinzawa, Yumiko Takeda, Tsuneo Takahashi
Melatonin's gastroprotective and antistress roles involve both central and peripheral effects
Kimitoshi Kato, Satoshi Asai, Ichiro Murai, Toshihito Nagata, Yasuo Takahashi, Sachiko Komuro, Ariyoshi Iwasaki, Koichi Ishikawa, Yasuyuki Arakawa
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer
Hyun Soo Kim, Dong Ki Lee, Kwang Hyun Kim, Yon Soo Jeong, Jae Woo Kim, Jeong In Seo, Soon Ku Baik, Sang Ok Kwon, Mee Yon Cho
Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers
Akihiko Okumura, Tetsuya Ishikawa, Kentaro Yoshioka, Ryugo Yuasa, Yoshitaka Fukuzawa, Shinichi Kakumu
The sympathetic nervous system promotes carbon tetrachloride-induced liver cirrhosis in rats by suppressing apoptosis and enhancing the growth kinetics of regenerating hepatocytes
Koumei Hamasaki, Masahiro Nakashima, Shinji Naito, Yuri Akiyama, Akira Ohtsuru, Yoichi Hamanaka, Chao-Tien Hsu, Masahiro Ito, Ichiro Sekine
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication
Hiroshi Miki, Shoji Kobayashi, Hideo Harada, YasuhiroYamanoi, Toshio Uraoka, Masaaki Sotozono, Masaki Ohmori
Laparoscopic cholecystofistulectomy for preoperatively diagnosed cholecystoduodenal fistula
Fumio Chikamori, Kazuya Okumiya, Atsushi Inoue, Nobutoshi Kuniyoshi
Primary intestinal lymphangiectasia successfully treated with octreotide
Ganji Kuroiwa, Tetsuji Takayama, Yasushi Sato, Yasuo Takahashi, Tomoki Fujita, Atsushi Nobuoka, Takehiro Kukitsu, Junji Kato, Sumio Sakamaki, Yoshiro Niitsu
Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
Takashi Someya, Yoshiyuki Suzuki, Yasuji Arase, Masahiro Kobayashi, Fumitaka Suzuki, Akihito Tsubota, Satoshi Saitoh, Kazuaki Chayama, Naoya Murashima, Kenji Ikeda, Hiromitsu Kumada
What are the objectives of treatment for intestinal lymphangiectasia?
Hiroki Takahashi, Kohzoh Imai
Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B
Kendo Kiyosawa, Eiji Tanaka